发明名称 Method and apparatus for monitoring anti-platelet agents
摘要 A blood coagulation analyzer, such as the Thrombelastograph(R) (TEG(R)) blood coagulation analyzer is utilized to measure continuously in real time, the clotting process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood coagulation parameters. The measured blood coagulation parameters permit confirmation of the attainment of therapeutic level of GPIIb/IIIa receptor blockade; individualized dosing assessment to evaluate attainment of adequate GPIIb/IIIa receptor blockade; individualized dosing assessment required to reach adequate GPIIb/IIIa receptor blockade; illustration of the rate of diminishment of platelet inhibition or inhibition recovery after treatment with platelet-inhibition drugs; evaluation of the interaction effect of a combination of thrombolytic or any other agents or conditions effecting hemostasis and platelet-inhibiting agents on patient hemostasis.
申请公布号 US6613573(B1) 申请公布日期 2003.09.02
申请号 US20000591371 申请日期 2000.06.09
申请人 HAEMOSCOPE CORPORATION 发明人 COHEN ELI
分类号 A61K31/195;A61K31/197;A61K31/352;A61K31/727;A61K38/46;A61K38/48;A61P7/02;A61P7/04;G01N11/16;G01N33/15;G01N33/49;G01N33/86;(IPC1-7):G01N33/86 主分类号 A61K31/195
代理机构 代理人
主权项
地址